Lallemand Inc.

Lallemand develops, produces and markets high-value yeast and bacteria products including probiotics, silage inoculants and yeast derivatives. These innovative solutions positively benefit animal nutrition and well-being, forage management and the animal environment. Using sound science, proven results and knowledge from experience, Lallemand applies the right strains for the right applications to have the greatest impact for our customers. Lallemand Animal Nutrition is committed to optimizing animal performance and well-being with specific, natural microbial product and service solutions. Lallemand has offices; yeast and bacteria production facilities; and distribution centers around the world to serve a growing number of countries everyday.

Company details

6120 West Douglas Avenue , Milwaukee , Wisconsin 53218 USA

More Office Locations Locations Served

Business Type:
Manufacturer
Industry Type:
Agriculture - Livestock
Market Focus:
Globally (various continents)

This company also provides solutions for other industrial applications.
Please, visit the following links for more info:


A higher level of expertise, leadership and industry commitment with long-term and profitable solutions move our partners Forward.

CONDUCTING BUSINESS WITH CUSTOMER EMPHASISLallemand Animal Nutrition takes a strategic approach to its business activities – always with the customer in mind.

Lallemand Animal Nutrition has:

  • Strong relationships and reliance on distribution network partners;
  • Global vision with local action;
  • Continuous investments to improve quality, productivity and producer profitability;
  • “Field-Led and Science-Supported” educational strategy and transfer of knowledge.

Our History

Lallemand’s Animal Nutrition activities began in 1988 with the acquisition of the Equilait / Equipharm bacteria plant in Aurillac (France) and an agreement signed with Omnium Homeopathique Francais (O.H.F.), which led to the development of two active dry yeasts: LEVUCELL SC and LEVUCELL® SB.

North American sales were strengthened in 1993 by the acquisition of Quali Tech Inc, a direct-fed microbials and silage inoculants business, which lead to the formation of Lallemand Animal Nutrition North America with the acquisition of Biotal in 2002.

The business has continued to grow rapidly through a combination of acquisitions around the world such as the purchases of Agrig8 in Australia, Katec in Brazil and internal development, to become a major global supplier of probiotics, silage inoculants and yeast derivatives.